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Background: Transcatheter closure of various congenital and acquired vascular malforma-
tions with Amplatzer Vascular plugs I and II has been established. Here we present our
experience with device closure.
Materials and methods: Between October 2006 and August 2012, nine (three males and six
females) patients aged between 11 months and 62 years (mean age 19 years) underwent
percutaneous device closure with AVP I and II vascular plugs for congenital and acquired
arteriovenous malformation and cardiac diverticulum are presented here.
Results: One case of coronary cameral fistula, four cases of pulmonary arteriovenous fistula,
one case of large major aortopulmonary collaterals (in tetralogy of Fallot closed before
intracardiac repair), one case of congenital cardiac diverticulum, one case of fistula be-
tween external carotid artery and internal jugular vein and one case of iatrogenic carotid
jugular fistula were successfully closed with AVP I and II plugs. Overall in nine cases, 16
AVP I and II plugs were deployed to occlude feeding vessels and one cardiac diverticulum.
The technical success rate was 100%. No major complications were observed.
Conclusion: Amplatzer vascular plugs can be used successfully for closure of various
congenital and acquired vascular malformations with good result.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Introduction
Portsmann was the first to report transcatheter blood vessel
closure in 1967. He had closed patent ductus arteriosus by
using Ivalon plug.1 Advancements in technology have resulted
in development of new devices to the interventionist’s
armamentarium. Amplatzer vascular plugs (AVP; AGA Medi-
cal, Golden Valley, MN, USA) have emerged as the new tools
for transcatheter embolizations in the peripheral vasculature,
occlusion of abnormal vessel communications and congenital, þ91 9914209517 (mobile
com (M.K. Rohit).
2013, Cardiological Sociecardiac defects. The AVP is a self-expanding cylindrical de-
vice, similar to the Amplatzer septal and ductal occluding
devices.2. The Amplatzer vascular plug
The AVP is a self-expandable cylindrical device made of
nitinol mesh wires. Its structure allows the device to be
compressed inside the catheter, which returns to its intended).
ty of India. All rights reserved.
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vessel. Platinum markers are present on both ends of the
device. A stainless steel micro screw is welded to one of the
platinum marker bands, which allows attachment to the
135 cm long delivery cable. The available device size ranges
from 4 mm to 16 mm in AVP I and 4 to 22 mm in AVP II, with
increments of 2 mm. It is preloaded in a loader and delivered
through guiding catheters ranging in size from 5 F to 10 F.2,3
Once positioned by holding the delivery shaft steady and
pulling the outer guiding catheter back, it is released by
rotating the delivery cable counter clockwise. Device is
selected 30%e50% larger than the vessel diameter. Its flexi-
bility allows it to adjust to the vessel shape and over sizing
prevents the migration of the device after deployment.
Amplatzer vascular plug II (AVP II) and more recently AVP III
and AVP IV were designed for better occlusive properties. It
contains a finer, more densely woven nitinol, braided in two
layers in the smaller devices and three layers in devices
bigger than 10 mm.4 AVP I and IV are single layered, and AVP
II and III are multilayered. The use of vascular plug I in pa-
tients with congenital and acquired cardiovascular disease
had been reported,2 more recently there was increasing use
of vascular plug II in patients with congenital and acquired
defects.4e6 AVP I used for short landing zones, AVP II used for
variable landing zones with shorter occlusion time, AVP III
for high-flow embolization and AVP IV used for tortuous
vessel and rapid embolization.
We describe here our experience with AVP for occluding
various peripheral and central arteries and veins, including
occlusion of pulmonary arteriovenous malformations
(PAVMs) and cardiac diverticulum.2.1. Materials and methods
Between October 2006 and August 2012, nine patients (3
males, 6 females) aged between 11months and 62 years (mean
age, 19 years) underwent percutaneous vessel closurewith the
AVP. Transfemoral approach was the preferred vascularTable 1 e Patient characteristics and procedures done.
Case
no
Sex Age
(years)
Indication
1 Male 11 month Coronary cameral fistula Right cor
2 Male 62 Large PAVM Both lung
3 Female 34 Large PAVM Right low
4 Female 35 Large PAVM Right low
5 Male 12 Large PAVM and paradoxical
embolism
Left uppe
6 Female 12 Large MAPCA in tetralogy Fallot Right upp
7 Female 12 Cardiac diverticulum Left vent
8 Male 15 Large neck swelling Common
jugular v
9 Female 13 Large arteriovenous fistula External
jugular v
AVP e Amplatzer vascular plug, PAVM e Pulmonary arteriovenous malfoaccess and intravenous conscious sedation given for all the
procedures.
2.2. Results
Patient characteristics and treatment details are described in
Table 1. AVP was used for occluding various peripheral and
central arteries and veins, including occlusion of coronary
arteriovenous fistulas, PAVMs and cardiac diverticulum.3. Coronary arteriovenous fistula
An eleven-month-old male child with history of failure to
thrive and poor weight gain had continuous murmur in right
precordial region. Echocardiography showed right coronary
artery (RCA) fistula opening into right ventricle. Angiography
revealed a large fistula opening from RCA into right ventricle
(Fig. 1a). Judkin’s right (JR) catheter 5 F was used to hook RCA
through the 6 F carotid shuttle sheath (Cook, USA). Terumo
wire was passed from fistula to right ventricle and pulmonary
artery. Over this JR, 6 F Carotid shuttle sheath was passed up
to the point of delivery. Amplatzer vascular plug (AVP I) was
deployed. Therewas partial occlusion of the fistula and clearly
visible right coronary artery at end of the procedure (Fig. 1b).
There were no signs of RCA territory ischemia post-
intervention. Echocardiogram done 24 h later showed no re-
sidual flow across the fistula. On follow-up, the child had a
grade II systolic murmur and a weight gain of four and half
kilograms.4. Large pulmonary arteriovenous fistulas
(cases 2e5 Table 1)
4.1. Case 2
A 62-year-old male with history of headache and breathless-
ness had central cyanosis and clubbing on examination.
Echocardiography showed structurally normal heart.Location Delivery system Device for total
occlusion
onary artery Carotid shuttle sheath 6 F AVP I plug
s Cook sheath 6 F 2 AVP II plugs
er lobe segment Cook sheath 10 F AVP I plug
er lobe segment Cook sheath 11 F AVP II
r lobe segment Cook sheath 7 F 5 AVP I plugs
er lobe segment Judkins right 4 6 F AVP II plug
ricle Cook sheath 9 F 2 ADO devices and
AVP I plug
carotid to internal
ein
Carotid shuttle sheath 6 F AVP II plug
carotid to external
ein
Carotid shuttle sheath 6 F AVP II plug
rmation, MAPCA e Major aortopulmonary collateral arteries.
Fig. 1 e a. Coronary cameral fistula into right ventricle. b. Fistula closed by Amplatzer vascular plug I.
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raphy revealed two pulmonary arteriovenous fistulas, one
large fistula in the left posterior basal segment (12 mm)
(Fig. 2a) and other small fistula in right basal segment (6 mm)Fig. 2 e a. Left lower lobe pulmonary arteriovenous malformati
malformation. c. Left lower lobe pulmonary arteriovenous malf
pulmonary arteriovenous malformation closed by AVP II 8 mm(Fig. 2b). First the left lung fistula was hooked with 6 F Cooks
delivery sheath. AVP II 16 mm was deployed. Angiography
done 15 min later, revealed complete occlusion of the fistula
(Fig. 2c). Saturation improved to 92%. Thereafter, right lungon. b. Right lower lobe pulmonary arteriovenous
ormation closed by AVP II 16 mm plug. d. Right lower lobe
plug.
Fig. 3 e a. Right lower lobe arteriovenous malformation. b. Right lower lobe arteriovenous malformation closed by two AVP I
plugs.
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was deployed with complete occlusion of the fistula (Fig. 2d).
At end of procedure, systemic saturation improved to 96%. Six
months on follow-up, patient was asymptomatic with sys-
temic oxygen saturation of 97%.
4.2. Case 3, 4
A 34-year-old female with cyanosis and clubbing, structurally
normal heart having systemic desaturation of 84%. CT pul-
monary angiography showed arteriovenous fistula in right
basal posterior segment of lung. Right sided arteriovenous
fistula was demonstrated on angiography (Fig. 3a) with two
feeding arteries, one of 14 mm size and the other of 10 mm
size in the right lower lung. Site of feeder vessel was hooked
with 10 F Cooks delivery sheath. Two AVP I sized 18 mm and
12 mmwere deployed in the fistula. Angiography done 15min
later revealed complete occlusion of the fistula (Fig. 3b). Sys-
temic saturation improved to 98%.
A 35-year-old female with breathlessness and cyanosis,
and structurally normal heart had systemic oxygen saturationFig. 4 e a. Right lower lobe arteriovenous malformation. b. Righ
plug.of 70%. Angiography revealed a 15mmarteriovenous fistula in
the right lung (Fig. 4a). Arterial feeder vessel was hooked with
11 F Cooks delivery sheath and AVP II 22 mmwas deployed in
the fistula. Angiography done 15 min later revealed complete
closure of the fistula (Fig. 4b). Her saturation improved to 95%
with relief of dyspnea.
4.3. Case 5. Large PAVM with paradoxical embolism
A 12-year-old child with progressive cyanosis for five years
presented with headache, fever, single episode of right focal
seizure and weakness in his right half of body. On exami-
nation, he was drowsy with central cyanosis, clubbing and
tachypnea with systemic desaturation of 65%. He had struc-
turally normal heart. Neurological examination revealed loss
of power in right upper and lower extremities. Chest X-ray
showed normal cardiac size and inhomogeneous opacity
with fewer linear channels in left upper lung fields. Electro-
cardiogram and echocardiography were normal. Contrast
echocardiography suggested the presence of intrapulmonary
arteriovenous malformation with significant right-to-leftt lower lobe arteriovenous malformation closed by AVP II
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riovenous malformation in the left upper lobe (Fig. 5a). Pul-
monary angiography confirmed the presence of large left
intrapulmonary arteriovenous malformation with multiple
feeder vessels. The boy underwent percutaneous closure of
the PAVM with five Amplatzer vascular plugs using Cook 7 F
delivery sheath. It was done as a staged procedure. At first
stage, three AVP I plugs 14 mm, 12 mm and 10 mm were
deployed and oxygen saturation improved to 75%. After the
deployment of two more AVP I plugs 16 mm and 14 mm,
oxygen saturation improved further to 92% on room
air (Fig. 5b). Repeat chest X-ray showed marked reduction of
opacity.
A contrast enhanced CT scan (Fig. 5c) of his head revealed a
left-sided hypo-dense parietal lesion (5  4 cm) with cystic,
contrast ring enhancement and peri-lesional edema exerting
a significant mass effect. A left-sided osteoplastic craniotomy
was performed and white-yellowish pus was aspirated from
the encapsulated mass. The histopathology revealed a brain
abscess. He was put on empirical broad spectrum antibiotics.
Actinomycosis species were identified. Follow-up CT scan of
his head 7 weeks after surgery showed resolution of his brain
abscess lesion (Fig. 5d). At six months on follow-up, theFig. 5 e a. CT chest of large PAVM in left upper lobe. b. Angiograp
c. Left parietal-occipital abscess on CT head. d. CT head after supatientwas asymptomatic with a saturation of 96%with small
residual opacity on chest X-ray (Fig. 5b).5. Major aortopulmonary collaterals
5.1. Case 6. Closure of large aortopulmonary collateral
in tetralogy of Fallot
A 12-year-old male diagnosed case of tetralogy of Fallot with
large aortopulmonary collateral to the right upper lobe of lung.
He was planned for percutaneous closure of collateral prior to
total intracardiac repair of the defect. He had systemic desa-
turation of 84%. Aortogram with 6 F pigtail revealed large
aortopulmonary collateral to the right lung of size 8 mm
(Fig. 6a). In view of large collateral, our institute policy is to
deploy an Amplatzer vascular plug instead of multiple coils.
Judkins right 4 was used to hook the aortopulmonary collat-
eral and AVP II 9 mm was used to occlude the collateral.
Angiography done post device deployment revealed complete
occlusion of the collateral (Fig. 6b). Post procedure systemic
saturation was 78%. The patient was taken up for intracardiac
repair post procedure.hic image of post device closure of fistulae with AVP I plugs.
rgery and antibiotics.
Fig. 6 e a. Large aortopulmonary collateral to right lung. b. Occlusion of collateral with AVP II plug.
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A 12-year-old girl presented with palpitations and two epi-
sodes of syncope. Holter monitoring did not reveal any ven-
tricular tachycardia or sinus pause. Echocardiography
revealed a suspicious defect in left ventricular outflow tract.
Transesophageal echocardiography revealed a thickmuscular
wall diverticulum in left ventricular outflow tract with
dimension of 15  17 mm. Device closure of the diverticulum
was taken through right femoral arterial access. Angiogram
showedcardiac diverticulumanterior to left ventricle attached
to the left ventricular outflow tract via 8 mm shaft (Fig. 7a).
Diverticulum was hooked with 5 F Judkins right diagnostic
catheter and it was exchanged with 9 F Cooks delivery sheath.
Initial attempt was made to close with 10 mmAmplatzer duct
occluder I. But on release the device prolapsed into the diver-
ticulum. Thereafter 8 mm, AVP I was used to fill the divertic-
ulumwhichhad also prolapsed andfinally another 10 12mm
Amplatzer duct occluder I was placed at the neck of divertic-
ulum. Finally, the diverticulum was completely occluded. LeftFig. 7 e a. Left ventriculogram showing cardiac diverticulum an
completely occluded by AVP I plug and ADO I devices.ventricular angiography repeated two days later showed
complete occlusion of the diverticulum (Fig. 7b). Presently, she
is asymptomatic at one and half years of follow-up.7. Iatrogenic carotido-jugular arteriovenous
fistula
A 15-year-old male with neuroblastoma and obstructive hy-
drocephalus underwent emergency shunt surgery, during
which central venous catheter was placed in right internal
jugular vein by the anesthetist. Two weeks later, patient
noticed right neck swelling. Clinical examination revealed the
presence of thrill over the swelling. CT angiography of neck
vessels showed a large fistulous tract from right common
carotid artery to right internal jugular vein. In view of difficult
and high risk vascular access surgically, he was referred for
device closure. Angiography confirmed fistulous tract be-
tween brachiocephalic trunk and right internal jugular vein
(Fig. 8a). Judkins right catheter 6 F was placed in theterior to left ventricular outflow tract. b. Diverticulum
Fig. 8 e a. Iatrogenic right carotido-jugular arteriovenous fistula. b. Fistula closed by AVP II.
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fistulous tract into the internal jugular vein. Carotid shuttle
sheath 6 Fwas advanced into the internal jugular vein through
the fistula. AVP II 8 mm was deployed to occlude the fistula.
Angiography done after 15 min showed complete occlusion of
the fistula (Fig. 2b). Repeat CT angiography after two months
showed complete occlusion of the fistulous tract.8. Carotido-jugular fistula: arteriovenous
fistula of left external carotid artery to left
internal jugular vein
A 13-year-old girl presented with increasing neck swelling on
the left side of mandible for two years. Clinical examination
revealed a continuous murmur over the swelling. CT angiog-
raphy of neck vessels revealed a fistulous communication
between left external carotid artery and left internal jugularFig. 9 e a. Carotid jugular arteriovenous fistula. b.vein. Selective angiography with multipurpose catheter
confirmed the fistulous tract (Fig. 9a). Carotid shuttle sheath
6 F was advanced over the left external carotid artery. AVP II
12 mm was deployed across the fistulous tract. Angiography
after 15 min did not reveal any residual flow but the left
external carotid artery was completely occluded (Fig. 9b). Post
procedure she had recurrent vomiting that stabilized over 48 h
with anti-emetics. At one year of clinical follow-up, only mild
symptoms of jaw claudication existed.9. Discussion
Use of AVP I and II was approved by FDA in May 2004 and
September 2007, respectively. Their use had been reported for
various conditions, like peripheral vessel malformations,3
pulmonary AVMs,8e10 venous collaterals,11 aortopulmonary
collaterals,12 coronary fistulae,13e15 patent ductusFistula closed by Amplatzer vascular plug II.
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fenestrations,19 ventriculo-pulmonary connections,20 vena
cava aneurysms,21 perivalvular leaks,22 and porto-systemic
connections.23 AVP I device use was reported in many
studies which were mostly small series with lesser number of
reports on use of AVP II.4e6 Occlusion is not achieved imme-
diately after the deployment of the device. Due to this, the risk
of distal embolization during slow thrombosis of the device in
the vessels at risk like carotids remains with subsequent
neurological complications.24,25
Hill et al described the use of AVP I in patients with
congenital heart disease in United States across 11 centers.2
Fifty-two patients were included in that series. The most
commonly occluded vessels were aortopulmonary collaterals
(42%) and pulmonary AVM’s (32%). Venous collateral vessels,
trans-hepatic tracts, surgical shunts, PDA and coronary artery
fistulae were also treated. 94% complete occlusion rate at the
time of catheterization was noted with AVP I. No major
complications were reported. One device had to be electively
removed from a PDA due to significant residual flow.
Schwartz et al26 reported AVO I and II for occlusion of
various congenital heart diseases. AVP II had taken over AVP I
for occlusion procedures because of its better occlusive prop-
erties and lower profile design. It had been particularly useful
for occlusion of high-flow tubular lesions (type CeE PDA’s,
aortopulmonary collaterals, AVMs). In our study, a case of TOF
who was being taken up for corrective surgery underwent
successful closure of major aortopulmonary collateral by AVP
II device just prior to surgery.
In our study, transcatheter embolization with vascular
plugs was performed for pulmonary arteriovenous malfor-
mations, coronary arteriovenous malformation, major aorto-
pulmonary collateral, iatrogenic carotido-jugular fistula,
external carotid artery to internal jugular vein fistula and
congenital cardiac diverticulum. AVP I was used in three pa-
tients and AVP II was used in six patients. No complications
were seen secondary to AVP closure of the pulmonary artery
feeders. Sixteen AVP I and II vascular plugs of 6e22 mm in
diameter were used in nine patients to occlude nine vessels
and one diverticulum. 5 F guiding sheaths were used for 4-, 6-,
and 8mmsize plugs, 6 F guiding sheathswere used for 10- and
12 mm plugs, 8 F guiding sheath was used for a 16 mm plug
and 11 F guiding sheath was used for 22 mm plug. The
diameter of the AVP was chosen to be approximately 30%e
50% greater than that of the blood vessel, as recommended by
the manufacturer. The radio-opacity of the device was suffi-
cient, allowing easy visualization under fluoroscopy. In each
case, the final localization of the AVP was confirmed with
angiography before its release. The technical success rate was
100%, with total occlusion of all the target vessels. There was
no incident of device embolization, or vascular disruption.
There was device dislodgement in the case with cardiac
diverticulum, which was managed with additional device
occlusion. Patency of the embolized vessel was checked with
serial contrast injections from the guiding catheter and oc-
clusion of the embolized vessel was confirmed by final angi-
ography. Target vessel occlusion time after deployment of the
AVP was 6e10 min (mean, 7.5) in pulmonary arteries,
10e35 min (mean, 24.4) in systemic arteries. Follow-up imag-
ing (range, 1e6months) was obtained with contrast enhancedcomputed tomography (CT) in four patients and conventional
angiography in five patients all of which showed complete
occlusion of the embolized vessels. Clinical follow-up was
done in all the patients.
Pulmonary AVMswith afferent arteriesmore than 3mm in
diameter are known to cause serious neurological symptoms,
and its treatment is advocated to prevent paradoxical embo-
lization.27 Embolization with coils or detachable balloons was
the preferred treatment for PAVMs in the past era. Coil
embolization of PAVMs had certain shortcomings, such as the
need for multiple coils to occlude a single vessel, incomplete
occlusion of the vessel, systemic embolization and reflux of
coils, and recanalization rates ranging from 5% to as high as
57%.28e30 The AVP developed as a new tool for the treatment
of PAVMs.2,8,9,12,27,31 Additionally, the risk of embolic device
migration and dislodgement was reduced. In our study, we
achieved a 100% occlusion rate of PAVMs with no device
embolization or migration. In this study in low-pressure
venous systems like PAVMs, complete occlusion was ach-
ieved in 6e10 min (mean: 7.5 min). The time required for total
occlusion of a particular vessel increased with the increase in
both vessel diameter and size of the AVP used. Our results are
similar to those of Hill et al, who reported complete occlusion
within 10 min in 94% of targeted vessels compared to mean
occlusion time of 15min in our study.6 In our study, four cases
of PAVM were closed with total of nine plugs.
Duraisamy et al32 reported the first the use of AVP to
occlude a coronary fistula. AVP has many advantages over
other devices previously used for coronary fistula occlusion.
The AVP allows for precise deployment due to its complete
control of the device until its release and allows the operator
to confirm position with hand-injection angiograms via the
side-arm of a Tuohy-Borst connection. This is important
during occlusion of coronary fistula with branches arising
from proximal part of the fistula. Proximal migration can
result in occlusion of coronary artery branches which can
have fatal clinical consequences.33 While considering the
possibility of proximal migration of an oversized device in a
lesion that has wider proximal end, appropriate sizing of the
AVP needs to be understood. Due to the possibility of residual
shunts, it is good to plan in advance to ensure complete oc-
clusion, especially in locations that appear poorly suited for
placing a second plug or another device. In our study, a case of
coronary AV fistula was closed through the retrograde
approach which had less number of case reports as compared
to themore common antegrade approach. In this case, though
wehad poor visualization of the anatomy of the right coronary
artery due the huge coronary cameral fistula, we observed for
ischemic changes on electrocardiogram and blood pressure
for 30 min before deploying the vascular plug. AVP I was used
in the case.
Kelly et al34 first reported case of successful closure of a
subclavian artery to innominate vein malformation by
nonsurgical approach in a newborn infant. Sapire
et al described a neonate with a left subclavian artery to
innominate vein fistulae who presented in congestive heart
failure.35 A subclavian artery to subclavian vein fistula also
presenting in a neonate in heart failure was described by
Dogan et al.36 In both of these cases, the fistula was closed by
surgical ligation. In our study, a fistulous tract from left
i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) 5 3 6e5 4 5544external carotid artery to left internal jugular vein was closed
successfully by AVP II vascular plug.
Connie et al37 reported the successful use of an Amplatzer
vascular plug to close an iatrogenic complication of subcla-
vian arteriovenous fistula created during ICD implantation.
Subclavian arteriovenous fistula is an uncommon complica-
tion of central vein cannulation like pacemaker, ICD
implantation and central venous lines. Small subclavian
arteriovenous fistula may be asymptomatic and may go un-
noticed. Larger subclavian AVF may result in upper extremity
pain and swelling or decompensated congestive heart failure.
The AVP is approved for use in arterial and venous emboli-
zation in the peripheral vasculature,4 and successful reports
of its use in treatment of congenital and iatrogenic vascular
disease have been published.26,38 In our study we closed an
iatrogenic arteriovenous fistula formed between brachioce-
phalic artery and internal jugular vein after central line
insertion.
In this study, the AVP were used for achieving the total
occlusion of 16 vessels and a cardiac diverticulum7 in nine
patients. The AVP allowed targeted delivery, enabling more
precise placement within the artery. The position of the de-
vice was easily be verified with a test injection through the
guiding catheter prior to release. If device position was un-
satisfactory, it was repositioned or removed, which is an
important advantage of the AVP. The additional advantages of
this device over coil embolization are less risk of device
migration, a one-step easy procedure resulting in total oc-
clusion of the target vessel (quicker and less cost than
deploying multiple coils), the ability to be repositioned, and
MRI compatibility. Moreover, for lesions requiring multiple
coils to achieve occlusion, the average cost with the AVP oc-
clusion can be significantly lower than the coil embolization.
The use of the AVP also has some limitations. First, it re-
quires distal placement of a 5e8 F guiding catheter or sheath,
depending on the diameter of the vessel to be occluded. Sec-
ond, it is a cylindrical device and needs a short segment of
vessel (1.5e2 cm) with a constant diameter. Tapered vessels
may cause poor apposition of the device. Lastly, the AVP is not
suitable for occlusion of small vessels in which total occlusion
can be achieved with 1 or 2 coils. In such small vessels, coil
embolization is less expensive and does not require distal
placement of a 5 F guiding catheter.10. Conclusion
AVP is a simple and effective device, which allows precise,
reliable, and cost-effective occlusion of targeted vessels in
various vascular territories in selected cases without signifi-
cant complications. Although long-term results are not yet
available, due to the reported advantages of this device,
worldwide use is rapidly growing. More research is required in
larger series to determine the long-term role of the AVP as a
vessel occluder.Conflicts of interest
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